Holen Sie sich die Stockscreener-App
4.68
3.90%
-0.19
Handel nachbörslich:
4.74
0.06
+1.28%
Cytomx Therapeutics Inc Aktie (CTMX) Neueste Nachrichten
CytomX Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
CytomX Therapeutics Hits Day High with Strong 7.48% Intraday Surge - Markets Mojo
Movement Recap: Is CytomX Therapeutics Inc benefiting from interest rate changes2026 Setups & Step-by-Step Swing Trade Plans - baoquankhu1.vn
How The CytomX Therapeutics (CTMX) Story Is Shifting With Lofty P/E Assumptions And New Targets - Yahoo Finance
Short Squeeze: Is CytomX Therapeutics Inc a good ESG investment2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Attachment - GlobeNewswire
Analysts Offer Insights on Healthcare Companies: CytomX Therapeutics (CTMX) and Illumina (ILMN) - The Globe and Mail
Where CytomX Therapeutics Stands With Analysts - Benzinga
CytomX Therapeutics (NASDAQ:CTMX) Receives "Buy" Rating from Guggenheim - MarketBeat
CytomX Therapeutics (CTMX) Analyst Ratings Reiterate 'Buy' Stance | CTMX Stock News - GuruFocus
Earnings Recap: Is CytomX Therapeutics Inc benefiting from interest rate changes2025 Winners & Losers & Low Risk High Reward Ideas - baoquankhu1.vn
Why CytomX Therapeutics Inc. stock is a value investor pickMarket Growth Report & Consistent Profit Trade Alerts - Naître et grandir
Aug Highlights: Can CytomX Therapeutics Inc disrupt its industryWeekly Trading Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Risks Report: Can CytomX Therapeutics Inc disrupt its industryJuly 2025 Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Market Fear: Whats the profit margin of CytomX Therapeutics IncWeekly Stock Recap & Precise Swing Trade Alerts - baoquankhu1.vn
Risk Report: Whats the profit margin of CytomX Therapeutics IncJuly 2025 News Drivers & Community Consensus Stock Picks - baoquankhu1.vn
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - Bitget
Kynam Capital files 5.29% stake in CytomX (NASDAQ: CTMX) - Stock Titan
CTMX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CytomX emerges from masked obscurity | ApexOncoClinical Trials news and analysis - Oncology Pipeline
CytomX Therapeutics Target of Unusually High Options Trading (NASDAQ:CTMX) - MarketBeat
CytomX Therapeutics, Inc. to Announce Full Year 2025 Financial Results on March 16, 2026 - Quiver Quantitative
CTMX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CytomX Therapeutics, Inc. (CTMX): Investor Outlook Reveals 55.71% Potential Upside - DirectorsTalk Interviews
CTMXCytomx Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Earnings Recap: Is CytomX Therapeutics Inc a good ESG investment2025 Stock Rankings & Proven Capital Preservation Methods - baoquankhu1.vn
CytomX Therapeutics (CTMX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is CytomX Therapeutics Inc stock showing strong momentumJuly 2025 Sector Moves & Low Risk High Reward Ideas - baoquankhu1.vn
Will CytomX Therapeutics Inc. (6C1) stock rise with strong economyWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
Unmasking CytomXA Pioneer In Masked Therapeutics - RTTNews
Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating - Finviz
Is CytomX Therapeutics Inc. stock positioned well for digital economyDip Buying & Real-Time Buy Signal Notifications - mfd.ru
CTMX Should I Buy - Intellectia AI
Is CytomX Therapeutics Inc. (6C1) stock a fit for income portfolios2025 Buyback Activity & Expert Curated Trade Setups - mfd.ru
Will CytomX Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Big Picture & Entry Point Strategy Guides - mfd.ru
Can CytomX Therapeutics Inc. disrupt its industryEarnings Recap Summary & Fast Entry Momentum Alerts - mfd.ru
Market Trends: What hedge funds are buying CytomX Therapeutics Inc2025 Fundamental Recap & AI Enhanced Trading Signals - baoquankhu1.vn
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
CytomX Therapeutics, Inc. (CTMX) Investor Outlook: A Biotech Pioneer with a 61.87% Potential Upside - DirectorsTalk Interviews
CytomX Therapeutics Conference: CFO Highlights Varseta-M CRC Response Data, Next Catalysts - MarketBeat
FMR LLC's Strategic Acquisition of CytomX Therapeutics Inc Shares - GuruFocus
CytomX at Guggenheim Summit: Promising CRC Treatment Path By Investing.com - Investing.com Canada
Stock Recap: Is CytomX Therapeutics Inc benefiting from interest rate changes2025 Institutional Moves & Capital Protection Trade Alerts - baoquankhu1.vn
How New Analyst Assumptions Are Rewriting The Story For CytomX Therapeutics (CTMX) - Yahoo Finance
CTMX: Masked ADC shows 28% response in late-line CRC; registrational study planned by 2027 - TradingView
Rally Mode: Can CytomX Therapeutics Inc navigate macro headwindsJuly 2025 PreEarnings & High Yield Equity Trading Tips - baoquankhu1.vn
CytomX Therapeutics2026 Funding Rounds & List of Investors - Tracxn
Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX) - The Globe and Mail
Analysts bullish ahead of colorectal cancer readout for CytomX Therapeutics, Inc. (CTMX) - MSN
CytomX Therapeutics, Inc. (CTMX) Investor Outlook: Exploring a 58.73% Potential Upside Amid Innovative Oncology Developments - DirectorsTalk Interviews
Analysis Recap: Whats the profit margin of CytomX Therapeutics IncWeekly Trend Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):